Overexpression and secretion of the soluble CTLA-4 splice variant in various autoimmune diseases and in cases with overlapping autoimmunity

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 4, 2013, Pages 336-341

  Alfadhli, Suad ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MESSENGER RNA;

3' UNTRANSLATED REGION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; ETHNICITY; EXON; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

3' UNTRANSLATED REGIONS; ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CTLA-4 ANTIGEN; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HETEROZYGOTE; HUMANS; KUWAIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA SPLICING; UP-REGULATION; YOUNG ADULT;

EID: 84875677284     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0391     Document Type: Article

References (50)

1. Aguilar F, Torres B, Sanchez-Roman J, et al. (2003) CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum Immunol 64:936-940.
2. Ahmed S, Ihara K, Kanemitsu S, et al. (2001) Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus Erythematosus in the Japanese population. Rheumatol Oxford 40:662-667.
3. AlFadhli S, Kharrat N, AlRebai A (2010) Genome scan metaanalysis in systemic lupus erythematosus strong linkagewith loci 6p22.3-p21.1 and 2q31.1-34. J Med Genet Genomics 2:001-009.
4. Anjos S, Nguyen A, Ounissi-Benkalha H, et al. (2002) A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4. J BiolChem 277:46478-46486.
5. Ban Y, Davies TF, Greenberg DA, et al. (2003) Analysis of the CTLA-4, CD-28, and inducible co-stimulatory (ICOS) gene in thyroid diseases. Genes Immun 4:586-593.
6. Baretto M, Santos E, Ferreira R, et al. (2004) Evidence for CTLA-4 as a susceptibility gene for systemic lupus erythematosus. Hum Genet 12:620-626.
7. Barton A, Jury F, Eyre S, et al. (2004) Haplotype analysis in simplex families and novel analytic approaches in a case- control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum 50:748-752.
8. Barton A, Myerscough A, John S, et al. (2000) A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated- 4 (CTLA-4) is not associated with rheumatoid arthritis. Rheumatology 39:63-66.
9. Bengtsson AA, Rylander L, Hagmar L, et al. (2002) Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology 41:563-571.
10. Budarf ML, Goyette P, Boucher G, et al. (2011) A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes Immun 12:51-58.
11. Chan IH, Tang NL, Leung TF, et al. (2010) Association of plasma soluble CTLA-4 with lung function and gene polymorphism in Chinese asthmatic children. Int Arch Allergy Immunol 152:113-121.
12. Chang WW, Zhang L, Yao YS, et al. (2012) Association between CTLA-4 exon-1 + 49A/G polymorphism and systemic lupus erythematosus: an updated analysis. Mol Biol Rep 39:9159-9165.
13. Chua KH, Puah SM, Chew CH, et al. (2010) Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Ann Hum Biol 37:274-280.
14. Conne B, Stutz A, Vassali J (2000) The 3¢ untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat Med 6:637-641.
15. D'Alfonso S, Rampi M, Bocchio D, et al. (2000) Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum 43:120-128.
16. Daroszewski J, Pawlak E, Karabon L, et al. (2009) Soluble CTLA- 4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms. Eur J Endocrinol 161:5787- 5793.
17. Donner H, Braun J, Seidl C (1997a) Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 82:4130-4132.
18. Donner H, Rau H, Walfish PG (1997b) CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 182:143-146.
19. Gonzalez-Escribano MF, Rodriguez R, Valenzuela A, et al. (1999) CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens 53:296-300.
20. Hadj-Kacem H, Kaddour N, Adyel FZ, et al. (2001) HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjogren's syndrome. Rheumatology 40:1370-1374.
21. Harley JB, Moser KL, Gaffney PM, et al. (1998) The genetics of human systemic lupus erythematosus. Curr Opin Immunol 10:690-696.
22. Heward J, Gordon C, Allahabadia A, et al. (1999) The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus. Ann Rheum Dis 58:193-195.
23. Hudson LL, Rocca K, Song YW, et al. (2002) CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet 111:452-455.
24. Kouki T, Sawai Y, Gardine CA (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165:6606-6611.
25. Kuersten S, Goodwin E (2003) The power of the 3 UTR: translational control and development. Nat Rev Genet 4:626-637.
26. Lee CS, Lee YJ, Liu HF (2003) Association of CTLA4 gene A-G polymorphism with rheumatoid arthritis in Chinese. Clin Rheumatol 22:221-224.
27. Lee YH, Choi SJ, Ji JD, et al. (2002) No association of polymorphisms of the CTLA-4 exon 1 (+ 49) and promoter (-318) genes with rheumatoid arthritis in the Korean population. Scand J Rheumatol 31:266-270.
28. Lesage S, Goodnow CC (2001) Organ-specific autoimmune disease: a deficiency of tolerogenic stimulation. J Exp Med 194:31-36.
29. Liu MF, Wang CR, Chen PC, et al. (2003) Increased expression of soluble cytotoxic T- lymphocyte associated antigen-4 molecule in patients with systemic lupus erythematosus. Scand J Immunol 57:568-572.
30. Liu MF, Wang CR, Lin LC, et al. (2001) CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus 10:647-649.
31. Lowe RM, Graham J, Sund G (2000) The length of the CTLA-4 microsatellite (AT)n-repeat affects the risk for type 1 diabetes Diabetes Incidence in Sweden Study Group. Autoimmunity 32:173-180.
32. Magistrelli G, Jeannin P, Herbault N, et al. (1999) A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 29:3596-3062.
33. Matsushita M, Tsuchiya N, Shiota M, et al. (1999) Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method. Tissue Antigens 54:578-584.
34. Mehrian R, Quismorio FP Jr., Strassmann G, et al. (1998) Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum 41:596-602.
35. Milicic A, Brown MA, Wordsworth BP (2001) Polymorphism in codon 17 of the CTLA-4 gene (49 A/G) is not associated with susceptibility to rheumatoid arthritis in British. Caucasians Tissue Antigens 58:50-54.
36. Oaks MK, Hallett KM (2000) Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 164:5015-5018.
37. Parks CG, Hudson LL, Cooper GS, et al. (2004) CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. Lupus 13:784-791.
38. Sato S, Fujimoto M, Hasegawa M, et al. (2004) Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis. Rheumatology 43:1261-1266.
39. Saverino D, Brizzolara, Simone R, et al. (2007) Soluble CTLA-4 in autoimmune thyroid disease; Relationship with clinical status and possible role in the immune regulation. Clin Immunol 123:190-198.
40. Seidl C, Donner H, Fischer B, et al. (1998) CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigen 51:62-65.
41. Simone R, Brizzolara R, Chiappori A, et al. (2009) A functional soluble form of CTLA-4 is present in serum of celiac patients and correlates with mucosal injury and iTG antibody production. Intl Immunol 21:1037-1042.
42. Takeuchi F, Kawasugi K, Mori M, et al. (2006) The genetic contribution of CTLA-4 dimorphisms in promoter and exon 1 regions in Japanese patients with rheumatoid arthritis. Scand J Rheumatol 35:154-155.
43. Takeuchi F, Kawasugi K, Nabeta H, et al. (2003) CTLA-4 dimorphisms in Japanese patients with systemic lupus erythematosus. Clin Exp Rheumatol 21:527-528.
44. Umemura T, Ota M, Hamano H (2008) Association of autoimmune Pancreatis with cytotoxic T-lymphocyte Antigen 4. Gastroenterology 103:588-594.
45. Vyse TJ, Kotzin BL (1996) Genetic basis of systemic lupus erythematosus. Curr Opin Immunol 8:843.
46. Wan B, Nie H, Liu A, et al. (2006) Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J Immunol 177:8844-8850.
47. Wang XB, Kakoulidou M, Giscombe R (2002) Abnormal expression of CTLA-4 T cells from patients with Myasthenia gravis: effect of an AT rich gene sequence. J Neuroimmunol 130:224-228.
48. Wong CK, Lit LC, Tam LS, et al. (2005) Aberrant production of soluble co-stimulatory molecules CTLA-4,CD-28, CD-80 and CD-86 in patients with Systemic Lupus Erythematosus. Rheumatology 44:989-994.
49. Xu Y, Graves PN, Tomer Y, et al. (2002) CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4. Cell Immunol 215:133-140.
50. Yanagawa T, Gomi K, Nakao E, et al. (2000) CTLA4 gene polymorphism in Japanese patients with rheumatoid arthritis. J Rheumatol 27:2740-2742.